Altimmune, Inc. (ALT)
NASDAQ·Healthcare·Biotechnology
$2.76
-1.61%
Mkt Cap $251.09M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 5, 2026 | $556 | $26.00K | +4576.26% | -$0.25 | -$0.27 | -8.00% | — | — |
| Q4 2025 Nov 6, 2025 | $560 | $5.00K | +792.86% | -$0.29 | -$0.21 | +27.59% | — | — |
| Q3 2025 Aug 12, 2025 | $1.43K | $5.00K | +249.90% | -$0.32 | -$0.27 | +15.62% | — | — |
| Q2 2025 May 13, 2025 | $560 | $5.00K | +792.86% | -$0.35 | -$0.26 | +25.71% | — | — |
| Q1 2025 Feb 27, 2025 | $1.00K | $5.00K | +400.00% | -$0.34 | -$0.33 | +2.94% | — | — |
| Q4 2024 Nov 12, 2024 | $714 | $5.00K | +600.28% | -$0.36 | -$0.32 | +11.11% | — | — |
| Q3 2024 Aug 8, 2024 | $714 | $5.00K | +600.28% | -$0.34 | -$0.35 | -2.94% | — | — |
| Q2 2024 May 9, 2024 | — | $5.00K | — | -$0.36 | -$0.34 | +5.56% | — | — |
| Q1 2024 Mar 27, 2024 | $2.14K | $37.00K | +1626.55% | -$0.35 | -$0.33 | +5.71% | — | — |
| Q4 2023 Nov 7, 2023 | $857 | $362.00K | +42140.37% | -$0.40 | -$0.39 | +2.50% | — | — |
| Q3 2023 Aug 10, 2023 | $3.00K | $6.00K | +100.00% | -$0.44 | -$0.32 | +27.27% | — | — |
| Q2 2023 May 11, 2023 | — | $21.00K | — | -$0.49 | -$0.40 | +18.37% | — | — |
| Q1 2023 Feb 28, 2023 | $28.86K | $110.00K | +281.19% | -$0.52 | -$0.43 | +17.31% | — | — |
| Q4 2022 Nov 10, 2022 | $867.83K | $2.00K | -99.77% | -$0.49 | -$0.48 | +2.04% | — | — |
| Q3 2022 Aug 11, 2022 | $871.50K | $8.00K | -99.08% | -$0.45 | -$0.42 | +6.67% | — | — |
| Q2 2022 May 12, 2022 | $1.03M | $32.00K | -96.90% | -$0.57 | -$0.44 | +22.81% | — | — |
| Q1 2022 Mar 15, 2022 | $90.33K | $3.28M | +3528.42% | -$0.64 | -$0.49 | +23.44% | — | — |
| Q4 2021 Nov 9, 2021 | $146.23K | $157.56K | +7.75% | -$0.36 | -$0.81 | -125.00% | — | — |
| Q3 2021 Aug 10, 2021 | $1.89M | $137.62K | -92.72% | -$0.44 | -$0.40 | +9.09% | — | — |
| Q2 2021 May 17, 2021 | $2.10M | $837.52K | -60.12% | -$0.39 | -$0.38 | +2.56% | — | — |